Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
For the full show notes, visit [] EPISODE 143: OHIO PHARMACISTS ASSOCIATION ANNUAL CONFERENCE RECAP APRIL 2022 PLUS INTERVIEWS WITH EMLAH TUBUO, PHARMD AND GREG KRAMP, PHARMD Todays episode includes a recap of my weekend at the Ohio Pharmacist Association (OPA) Annual Conference April 1-3, 2022, and brief interviews with Ohio pharmacists Emlah Tubuo, PharmD and Greg Kramp, PharmD
As there is no reliable evidence of its benefits or long-term effects, its impossible to say how safe or effective this practice is
Source: Coskun et al., The Lancet 2022 Phase 2 Results Phase 2 -- Obesity (NEJM 2023) NCT04881760 | Published: New England Journal of Medicine , 2023 (Jastreboff AM, et al.) This was the landmark Phase 2 trial that put retatrutide on the map
This makes it an invaluable tool for individuals looking to kickstart their weight loss journey and overcome obstacles that may have hindered their progress in the past
Side effects were more common with the medications, particularly nausea and other digestive issues, and some participants discontinued treatment as a result
